Sensus Healthcare (SRTS) Competitors $3.36 +0.01 (+0.30%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRTS vs. BFLY, TMCI, RXST, SNWV, NPCE, STIM, CATX, CLPT, OM, and NNOXShould you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Butterfly Network (BFLY), Treace Medical Concepts (TMCI), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Neuronetics (STIM), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), Outset Medical (OM), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Sensus Healthcare vs. Its Competitors Butterfly Network Treace Medical Concepts RxSight Sanuwave Health NeuroPace Neuronetics Perspective Therapeutics ClearPoint Neuro Outset Medical Nano-X Imaging Butterfly Network (NYSE:BFLY) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations. Does the media prefer BFLY or SRTS? In the previous week, Sensus Healthcare had 20 more articles in the media than Butterfly Network. MarketBeat recorded 22 mentions for Sensus Healthcare and 2 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.86 beat Sensus Healthcare's score of -0.16 indicating that Butterfly Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders believe in BFLY or SRTS? 37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer BFLY or SRTS? Butterfly Network presently has a consensus target price of $3.00, indicating a potential upside of 107.61%. Sensus Healthcare has a consensus target price of $8.00, indicating a potential upside of 138.24%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Butterfly Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Butterfly Network 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, BFLY or SRTS? Sensus Healthcare has lower revenue, but higher earnings than Butterfly Network. Sensus Healthcare is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioButterfly Network$82.06M4.43-$72.49M-$0.28-5.16Sensus Healthcare$41.81M1.32$6.65M-$0.06-55.97 Is BFLY or SRTS more profitable? Sensus Healthcare has a net margin of -2.26% compared to Butterfly Network's net margin of -71.79%. Sensus Healthcare's return on equity of -1.58% beat Butterfly Network's return on equity.Company Net Margins Return on Equity Return on Assets Butterfly Network-71.79% -30.53% -21.80% Sensus Healthcare -2.26%-1.58%-1.41% Which has more volatility and risk, BFLY or SRTS? Butterfly Network has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500. SummarySensus Healthcare beats Butterfly Network on 8 of the 15 factors compared between the two stocks. Get Sensus Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRTS vs. The Competition Export to ExcelMetricSensus HealthcareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$54.99M$7.00B$5.71B$9.79BDividend YieldN/A1.32%3.77%4.10%P/E Ratio-55.7527.3030.9125.28Price / Sales1.3268.81404.2188.50Price / Cash7.7622.1625.2228.45Price / Book0.984.829.536.01Net Income$6.65M$178.31M$3.26B$265.34M7 Day Performance5.60%2.50%4.66%2.89%1 Month Performance-22.63%0.23%5.35%1.61%1 Year Performance-48.18%9.92%32.14%25.61% Sensus Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRTSSensus Healthcare2.0759 of 5 stars$3.36+0.2%$8.00+138.2%-48.3%$54.99M$41.81M-55.7540BFLYButterfly Network3.084 of 5 stars$1.43+1.8%$3.50+145.6%+49.7%$346.20M$82.06M-5.09460Gap UpTMCITreace Medical Concepts2.3677 of 5 stars$5.61+5.1%$10.52+87.5%+11.5%$335.83M$209.36M-6.60250RXSTRxSight1.4988 of 5 stars$7.92+1.5%$17.50+121.0%-84.0%$316.97M$139.93M-11.82220Trending NewsShort Interest ↑SNWVSanuwave Health2.3787 of 5 stars$35.49-2.1%$49.00+38.1%N/A$310.55M$36.19M-7.7940Gap UpNPCENeuroPace3.3582 of 5 stars$8.93-0.7%$17.00+90.4%+24.6%$294.86M$79.91M-10.63170News CoverageEarnings ReportShort Interest ↑Analyst RevisionSTIMNeuronetics2.3155 of 5 stars$4.66+5.4%$5.50+18.0%+198.2%$292.22M$74.89M-3.56180CATXPerspective Therapeutics1.7069 of 5 stars$3.89+5.7%$12.56+222.8%-73.2%$288.75MN/A0.0070News CoverageAnalyst RevisionCLPTClearPoint Neuro1.7021 of 5 stars$10.53+5.3%$19.67+86.8%+7.4%$279.89M$31.39M-13.86110Earnings ReportAnalyst RevisionOMOutset Medical1.3465 of 5 stars$14.16-5.9%$29.50+108.3%+33.4%$266.54M$113.69M-0.49520NNOXNano-X Imaging2.1229 of 5 stars$4.75+3.3%$9.50+100.0%-38.7%$265.78M$11.28M-5.28190Earnings ReportAnalyst Revision Related Companies and Tools Related Companies BFLY Alternatives TMCI Alternatives RXST Alternatives SNWV Alternatives NPCE Alternatives STIM Alternatives CATX Alternatives CLPT Alternatives OM Alternatives NNOX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRTS) was last updated on 8/18/2025 by MarketBeat.com Staff From Our Partners"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.